PsychoactiveMap

Not yet recruiting psychedelic research trials

Data as of 31 October 2026. Source: ClinicalTrials.gov records held by PsychoactiveMap, refreshed from a reviewed snapshot.

Not yet recruiting is a registry status. The study is registered but has not opened to participants yet. Status is reported by the study team and can change.

Educational information, not medical advice. A registry listing is not evidence of safety, benefit or results, and it is not a recommendation. PsychoactiveMap does not recruit, screen or refer participants. Status and other details are copied from the registry and can be out of date, so check the registry record and speak to a qualified health professional before any decision. Read the full disclaimer.

At a glance

Which substances

Counts per substance hub. Ketamine is limited to studies classified as psychiatric research, and records about disease-modifying therapy that match the abbreviation DMT are removed.

Substance hubStudies
Psilocybin33
MDMA5
LSD2
DMT1
Ketamine25
Ibogaine1

By phase

PhaseStudiesShare
Early Phase 134%
Phase 11827%
Phase 23146%
Phase 334%
Phase 423%
Not applicable69%
Not reported46%

Countries

Country is taken from the study's linked research site. 13 of 67 records have no country on file. The top 10 countries are shown.

CountryStudiesShare
United States3349%
Canada710%
Switzerland34%
China23%
Australia11%
Brazil11%
Spain11%
Finland11%
France11%
Israel11%

Registry-listed start years

Start yearStudies
2024 and later67

Study design

Topics named in study titles

A keyword match on registered titles, so one study can appear under more than one topic and a study can be missed. It describes what titles mention, nothing more.

TopicStudies
Depression and mood19
Other substance use8
Trauma and PTSD7
Cancer and end of life5
Pain and headache4
Suicidal thoughts4
Alcohol use2
Anxiety1

Latest registry-listed start dates

The 25 studies with the latest start dates, newest first. Dates may be estimated, including future dates; a listed date does not confirm that a study started. The order is not a ranking. Each ID links to its own ClinicalTrials.gov record.

Registry IDTitle as registeredStatusPhaseCountryRegistry dates
NCT07871877Medically Supervised Ibogaine With 12-Month Digital Recovery Support for Opioid Use DisorderNot yet recruitingPhase 1United StatesSource start: 2027-07-01 (estimated)
Source date details

Start: 2027-07-01 (precision: day; source type: ESTIMATED; estimated)

Primary completion: 2029-01-31 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2029-12-31 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.912Z; registry revision: 2026-10-13 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT07888933Intravenous Ketamine for Acute Suicidal Crisis and Psychiatric Hospital Length of StayNot yet recruitingPhase 2BrazilSource start: 2027-04-30 (estimated)
Source date details

Start: 2027-04-30 (precision: day; source type: ESTIMATED; estimated)

Primary completion: 2029-01-30 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2029-03-30 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.912Z; registry revision: 2026-10-22 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT07877987The Impact of Dose on the Impairing, Intoxicating, and Abuse-Related Effects of PsilocybinNot yet recruitingPhase 1United StatesSource start: 2027-03-01 (estimated)
Source date details

Start: 2027-03-01 (precision: day; source type: ESTIMATED; estimated)

Primary completion: 2030-06-30 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2030-06-30 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.912Z; registry revision: 2026-10-16 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT07774702Psilocybin for Methamphetamine Use DisorderNot yet recruitingPhase 2United StatesSource start: 2027-02-01 (estimated)
Source date details

Start: 2027-02-01 (precision: day; source type: ESTIMATED; estimated)

Primary completion: 2032-02-01 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2032-02-01 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.880Z; registry revision: 2026-09-21 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT07566104Group PACBT for DepressionNot yet recruitingPhase 2United StatesSource start: 2027-01 (estimated)
Saved start 2027-01-01 differs from reported 2027-01; the saved day is not established by this observation.
Source date details

Start: 2027-01 (precision: month; source type: ESTIMATED; estimated)

Primary completion: 2028-12 (precision: month; source type: ESTIMATED; estimated)

Study completion: 2028-12 (precision: month; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.566Z; registry revision: 2026-05-04 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT07852832Effects of Psilocybin on Craving in Nicotine DependenceNot yet recruitingPhase 2Not reportedSource start: 2027-01 (estimated)
Saved start 2027-01-01 differs from reported 2027-01; the saved day is not established by this observation.
Source date details

Start: 2027-01 (precision: month; source type: ESTIMATED; estimated)

Primary completion: 2027-12 (precision: month; source type: ESTIMATED; estimated)

Study completion: 2028-01 (precision: month; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.912Z; registry revision: 2026-10-01 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT07895134Psilocybin for Depression in VeteransNot yet recruitingPhase 2United StatesSource start: 2027-01-01 (estimated)
Source date details

Start: 2027-01-01 (precision: day; source type: ESTIMATED; estimated)

Primary completion: 2031-12-31 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2031-12-31 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.912Z; registry revision: 2026-10-26 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT07719088Psilocybin Effects on Healthy Aging Biomarkers and Purpose in LifeNot yet recruitingPhase 1United StatesSource start: 2026-12 (estimated)
Saved start 2026-12-01 differs from reported 2026-12; the saved day is not established by this observation.
Source date details

Start: 2026-12 (precision: month; source type: ESTIMATED; estimated)

Primary completion: 2028-04 (precision: month; source type: ESTIMATED; estimated)

Study completion: 2028-12 (precision: month; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.880Z; registry revision: 2026-10-13 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT07768618Electrophysiologic Mechanisms of Ketamine Antidepressant ResponseNot yet recruitingPhase 2United StatesSource start: 2026-12 (estimated)
Saved start 2026-12-01 differs from reported 2026-12; the saved day is not established by this observation.
Source date details

Start: 2026-12 (precision: month; source type: ESTIMATED; estimated)

Primary completion: 2031-12 (precision: month; source type: ESTIMATED; estimated)

Study completion: 2031-12 (precision: month; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.880Z; registry revision: 2026-08-17 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT07792538Psilocybin-Assisted Psychotherapy for Veterans With PTSDNot yet recruitingPhase 2NetherlandsSource start: 2026-12 (estimated)
Saved start 2026-12-01 differs from reported 2026-12; the saved day is not established by this observation.
Source date details

Start: 2026-12 (precision: month; source type: ESTIMATED; estimated)

Primary completion: 2028-12 (precision: month; source type: ESTIMATED; estimated)

Study completion: 2028-12 (precision: month; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.880Z; registry revision: 2026-08-28 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT07818720MLS101 Study in PMDDNot yet recruitingPhase 1Not reportedSource start: 2026-12 (estimated)
Saved start 2026-12-01 differs from reported 2026-12; the saved day is not established by this observation.
Source date details

Start: 2026-12 (precision: month; source type: ESTIMATED; estimated)

Primary completion: 2027-09 (precision: month; source type: ESTIMATED; estimated)

Study completion: 2027-12 (precision: month; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.880Z; registry revision: 2026-09-14 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT07833761ADEPT Psilocybin-Assisted Therapy With DBT for Borderline Personality DisorderNot yet recruitingPhase 1United StatesSource start: 2026-12-01 (estimated)
Source date details

Start: 2026-12-01 (precision: day; source type: ESTIMATED; estimated)

Primary completion: 2029-12-31 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2030-12-31 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.912Z; registry revision: 2026-09-22 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT07756736Psilocybin Therapy for Methamphetamine Use Disorder and HIVNot yet recruitingPhase 2United StatesSource start: 2026-11 (estimated)
Saved start 2026-11-01 differs from reported 2026-11; the saved day is not established by this observation.
Source date details

Start: 2026-11 (precision: month; source type: ESTIMATED; estimated)

Primary completion: 2029-04 (precision: month; source type: ESTIMATED; estimated)

Study completion: 2029-06 (precision: month; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.880Z; registry revision: 2026-08-11 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT07765693MDMA-AT for PTSD in Young Adults With Childhood TraumaNot yet recruitingPhase 2United StatesSource start: 2026-10-31 (estimated)
Source date details

Start: 2026-10-31 (precision: day; source type: ESTIMATED; estimated)

Primary completion: 2028-01-30 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2028-12-01 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.880Z; registry revision: 2026-08-20 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT07791901MB-PAT for Demoralization in Advanced Cancer ('PAT-MIND') TrialNot yet recruitingPhase 2CanadaSource start: 2026-10-30 (estimated)
Source date details

Start: 2026-10-30 (precision: day; source type: ESTIMATED; estimated)

Primary completion: 2027-12-20 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2027-12-31 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.880Z; registry revision: 2026-09-02 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT07683988Oral and Sublingual KetamineNot yet recruitingPhase 1Not reportedSource start: 2026-10-01 (estimated)
Source date details

Start: 2026-10-01 (precision: day; source type: ESTIMATED; estimated)

Primary completion: 2027-08-01 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2027-10-01 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.880Z; registry revision: 2026-07-06 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT07704762Clinical Trial of MDMA-Assisted Therapy for Military Service Members With Posttraumatic Stress DisorderNot yet recruitingPhase 2Not reportedSource start: 2026-10-01 (estimated)
Source date details

Start: 2026-10-01 (precision: day; source type: ESTIMATED; estimated)

Primary completion: 2028-01-01 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2028-10-01 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.880Z; registry revision: 2026-07-15 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT07839338A Study Comparing Oral Ketamine With Oral Midazolam for the Treatment of Major Depressive EpisodesNot yet recruitingPhase 3IndiaSource start: 2026-10 (estimated)
Saved start 2026-10-01 differs from reported 2026-10; the saved day is not established by this observation.
Source date details

Start: 2026-10 (precision: month; source type: ESTIMATED; estimated)

Primary completion: 2029-10 (precision: month; source type: ESTIMATED; estimated)

Study completion: 2029-10 (precision: month; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.912Z; registry revision: 2026-10-01 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT07820033Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Randomized Controlled TrialNot yet recruitingPhase 2CanadaSource start: 2026-09-14 (estimated)
Source date details

Start: 2026-09-14 (precision: day; source type: ESTIMATED; estimated)

Primary completion: 2028-12-30 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2029-07-30 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.880Z; registry revision: 2026-10-15 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT07433452The Effects of Psilocybin in Healthy Volunteers: Psychological, Biochemical and Electrophysiological Biomarkers.Not yet recruitingPhase 1Not reportedSource start: 2026-09-01 (estimated)
Source date details

Start: 2026-09-01 (precision: day; source type: ESTIMATED; estimated)

Primary completion: 2028-09-01 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2029-09-01 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.483Z; registry revision: 2026-02-25 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT07693257Neural Effects of Intravenous N,N-dimethyltryptamine (DMT)Not yet recruitingPhase 1United StatesSource start: 2026-09-01 (estimated)
Source date details

Start: 2026-09-01 (precision: day; source type: ESTIMATED; estimated)

Primary completion: 2028-09-01 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2029-09-01 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.880Z; registry revision: 2026-07-09 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT07801703Behavioural Activation Therapy and Ketamine for Treatment-Resistant DepressionNot yet recruitingPhase 2CanadaSource start: 2026-09 (estimated)
Saved start 2026-09-01 differs from reported 2026-09; the saved day is not established by this observation.
Source date details

Start: 2026-09 (precision: month; source type: ESTIMATED; estimated)

Primary completion: 2029-09 (precision: month; source type: ESTIMATED; estimated)

Study completion: 2029-09 (precision: month; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.880Z; registry revision: 2026-09-03 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT07824973Ketamine Treatment for Treatment-Resistant Depression - the Role of FramingNot yet recruitingNot applicableSwedenSource start: 2026-09 (estimated)
Saved start 2026-09-01 differs from reported 2026-09; the saved day is not established by this observation.
Source date details

Start: 2026-09 (precision: month; source type: ESTIMATED; estimated)

Primary completion: 2029-12 (precision: month; source type: ESTIMATED; estimated)

Study completion: 2030-08 (precision: month; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.880Z; registry revision: 2026-09-17 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT07693153The Effects of Psilocybin on Social ConnectednessNot yet recruitingPhase 1United StatesSource start: 2026-08-31 (estimated)
Source date details

Start: 2026-08-31 (precision: day; source type: ESTIMATED; estimated)

Primary completion: 2031-12-15 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2031-12-15 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.880Z; registry revision: 2026-07-09 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

NCT07745569Assessing of Behavioral Risk and Response to Electromagnetic and Psychedelic TherapiesNot yet recruitingPhase 2Not reportedSource start: 2026-12-31 (estimated)
Saved start 2026-08-31 differs from reported 2026-12-31; the saved day is not established by this observation.
Source date details

Start: 2026-12-31 (precision: day; source type: ESTIMATED; estimated)

Primary completion: 2030-06-30 (precision: day; source type: ESTIMATED; estimated)

Study completion: 2030-06-30 (precision: day; source type: ESTIMATED; estimated)

Observation retrieved: 2026-10-31T20:06:18.880Z; registry revision: 2026-10-30 (precision: day; source type: ACTUAL; actual). Source observations do not verify a different saved scalar or establish that an event occurred.

Other substance hubs

Psilocybin | MDMA | LSD | DMT | 5-MeO-DMT | Ayahuasca | Ketamine | Ibogaine

Registry status hubs

Recruiting | Active, not recruiting | Enrolling by invitation | Completed | Terminated | Suspended | Withdrawn

Phase hubs

Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Phase not applicable

All trial hubs | Learn | Disclaimer